AbbVie submitted an application for the Skyrizi induction regimen to the European Medicines Agency.
2 reports, 2 independent
Updated Oct 13
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AbbVie submitted an application for the Skyrizi induction regimen to the European Medicines Agency.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
European Medicines Agency
highest regulatory authority on medicines in the European Union